pioglitazone has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Asano, M; Chisaki, K; Imuta, H; Iwasawa, K; Morita, T; Nakajima, T; Nakamura, F; Okuda, Y; Omata, M; Yamada, N | 1 |
Cook, JA; Gilkeson, GS; Halushka, PV; Morrow, JD; Oates, JC; Reilly, CM | 1 |
Abe, I; Eto, K; Fujishima, M; Nakamura, Y; Ohya, Y | 1 |
Furumatsu, T; Inoue, H; Kawai, A; Kunisada, T; Nishida, K; Takada, I; Yoshida, A | 1 |
Ishii, H; Kanehara, H; Miyamori, I; Oida, K; Suzuki, J; Tohda, G | 1 |
Baba, T; Hayashi, Y; Katoh, T; Midorikawa, S; Onozaki, A; Sanada, H; Watanabe, T | 1 |
Liao, K; Xiao, Y; Yao, W; Yuan, T | 1 |
Cook, JL; Hanks, BC; Kuroki, K; Stoker, AM | 1 |
Chima, R; Kaplan, J; Nowell, M; Zingarelli, B | 1 |
Bogacka, I; Jastrzębski, JP; Kunicka, Z; Kurzyńska, A; Mierzejewski, K; Paukszto, Ł | 1 |
Bogacka, I; Golubska, M; Kunicka, Z; Kurzyńska, A; Mierzejewski, K | 1 |
11 other study(ies) available for pioglitazone and 9-deoxy-delta-9-prostaglandin d2
Article | Year |
---|---|
Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
Topics: Animals; Calcium; Calcium Channels, L-Type; Cell Division; Cell Line; Chromans; Hypoglycemic Agents; Membrane Potentials; Muscle, Smooth, Vascular; Pioglitazone; Platelet-Derived Growth Factor; Prostaglandin D2; Rats; Thiazoles; Thiazolidinediones; Troglitazone; Vasopressins | 1999 |
Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists.
Topics: Animals; Cells, Cultured; Cyclooxygenase 2; Female; Glomerular Mesangium; Isoenzymes; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxisomes; Pioglitazone; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 2000 |
Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle.
Topics: Analysis of Variance; Animals; Barium; Calcium; Chromans; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; Humans; Insulin Resistance; Ion Channels; Isoxazoles; Membrane Potentials; Muscle, Smooth, Vascular; Pioglitazone; Potassium Channels; Prostaglandin D2; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma.
Topics: Apoptosis; Cell Cycle; Cell Division; Cell Survival; Chondrosarcoma; Flow Cytometry; Humans; Male; Microscopy, Electron; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Cells, Cultured | 2002 |
Thrombomodulin expression by THP-1 but not by vascular endothelial cells is upregulated by pioglitazone.
Topics: Antibodies, Monoclonal; Blotting, Northern; CD4 Antigens; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Endothelium, Vascular; Flow Cytometry; Gene Expression Regulation; HL-60 Cells; Humans; Lipopolysaccharide Receptors; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Thrombomodulin; Thromboplastin; Transcription Factors; Tumor Cells, Cultured; Up-Regulation | 2002 |
Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione.
Topics: Alkaloids; Animals; Benzophenanthridines; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression; Glomerular Mesangium; Glucose; Male; Phenanthridines; Pioglitazone; Prostaglandin D2; Protein Kinase Inhibitors; Rats; Rats, Inbred OLETF; Rats, Sprague-Dawley; RNA, Messenger; Thiazolidinediones; Thymidine; Vascular Endothelial Growth Factor A | 2004 |
3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Apoptosis; bcl-Associated Death Protein; Caspase 3; Chromans; Male; Mice; Pioglitazone; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Zucker; Thiazolidinediones; Troglitazone | 2010 |
Evaluation of anti-inflammatory and chondroprotective effects of peroxisome proliferator-activated receptor gamma agonists in cartilage and synovial explants from dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage; Coculture Techniques; Dinoprostone; Dogs; Interleukin-1beta; Nitric Oxide; Pioglitazone; PPAR gamma; Prostaglandin D2; Synovial Membrane; Thiazolidinediones; Time Factors | 2010 |
Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis.
Topics: Adipokines; Animals; Cytokines; Hypoglycemia; Hypoglycemic Agents; I-kappa B Proteins; Inflammation; Lung; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pioglitazone; PPAR gamma; Prostaglandin D2; Sepsis; Thiazolidinediones | 2014 |
Transcriptome analysis of porcine endometrium after LPS-induced inflammation: effects of the PPAR-gamma ligands in vitro†.
Topics: Alternative Splicing; Animals; Benzamides; Endometrium; Female; Gene Expression Profiling; Inflammation; Lipopolysaccharides; Pioglitazone; PPAR gamma; Prostaglandin D2; Pyridines; Swine | 2021 |
PPARγ ligands modulate the immune response mediators in the pig myometrium - An in vitro study.
Topics: Animals; Antineoplastic Agents; Benzamides; Cytokines; Female; Gene Expression Regulation; Hypoglycemic Agents; Immunity; Myometrium; Pioglitazone; PPAR gamma; Pregnancy; Prostaglandin D2; Pyridines; Swine; Tissue Culture Techniques | 2021 |